Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Z-206 (oral mesalazine) in ulcerative colitis
jRCT2080221898Phase 2
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Salcrozine in autoimmune colitis, sponsored by Zeria Pharmaceutical Co., Ltd.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT2080221898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221898.